杭州鑫富药业2005年半年度报告（节录）_医药资讯

财务资料1、主要会计数据和财务指标单位：人民币元项 目本报告期末上年度期末本报告期末比上年度期末增减（％）流动资产240,214,800.49192,160,756.7625.01流动负债154,443,743.7946,476,128.14232.31总资产472,985,199.38358,700,400.5031.86股东权益（不含少数股东权益）316,891,455.59309,979,272.362.23每股净资产（注1）4.645.90-21.36调整后的每股净资产4.645.88-21.09项 目报告期（1－6月）上年同期本报告期比上年同期增减（％）净利润15,162,783.2318,632,697.97-18.62扣除非经常性损益后的净利润15,392,177.6817,605,755.08-12.57每股收益(注2)0.220.50-56净资产收益率4.78%16.50%减少11.72个百分点经营活动产生的现金流量净额1,413,260.398,614,386.61-83.59注1：本报告期末计算每股净资产的股本总数为6825万股，去年年底计算每股净资产的股本总数为5250万股。 注2：本报告期末计算每股收益的股本总数为6825万股，去年同期计算每股收益的股本总数为3750万股。 2、非经常性损益项目单位：人民币元非经常性损益项目金 额处置长期股权投资、固定资产、在建工程、无形资产、其他长期资产产生的损益-49,576.73各种形式的政府补贴900,000.00各项非经常性营业外收入、支出-427,131.41小计-386,708.14减：企业所得税影响数（所得税减少以“-”表示）157,313.69非经常性损益净额-229,394.453、利润及利润分配表单位：人民币元项 目本期数上年同期数合并数母公司合并数母公司一、主营业务收入134,010,850.83133,628,048.03113,521,757.53113,521,757.53减：主营业务成本89,231,422.9188,868,435.8568,319,177.2568,319,177.25主营业务税金及附加1,151,214.961,144,338.40676167.64676,167.64二、主营业务利润43,628,212.9643,615,273.7844,526,412.6444,526,412.64加：其他业务利润427,986.25427,986.25480,919.73480,919.73减：营业费用6,204,999.806,180,096.694,125,172.104,125,172.10管理费用12,303,620.2311,027,065.0310,041,558.2210,041,558.22财务费用2,166,266.641799562.231976787.701,976,787.70三、营业利润23,381,312.5425036536.0828,863,814.3528,863,814.35加：投资收益-49,576.73-1,704,800.27补贴收入90,000.0090,000.001,001,326.001,001,326.00营业外收入1,934.391,934.3995,920.9095,920.90减：营业外支出548,655.49548,655.49620,304.01620,304.01四、利润总额22,875,014.7122,875,014.7129,340,757.2429,340,757.24减：所得税7,712,231.487,712,231.4810,708,059.2710708059.27少数股东损益五、净利润15,162,783.2315,162,783.2318,632,697.9718,632,697.97加：年初未分配利润70,679,295.5270,679,295.5243,040,787.0943,040,787.09其他转入六、可供分配利润85,842,078.7585,842,078.7561,673,485.0661,673,485.06减：提取法定盈余公积提取法定公益金提取职工奖励及福利基金提取储备基金提取企业发展基金利润归还投资七、可供投资者分配的利润85,842,078.7585,842,078.7561,673,485.0661,673,485.06减：应付优先股股利提取任意盈余公积应付普通股股利10,500,000.0010,500,000.00转作股本的普通股股利八、未分配利润75,342,078.7575,342,078.7561,673,485.0661,673,485.064、利润及利润分配表附表单位：元项 目净资产收益率每股收益（元/股）全面摊薄加权平均全面摊薄加权平均主营业务利润13.77%13.92%0.640.72营业利润7.38%7.46%0.340.39净利润4.78%4.84%0.220.25扣除非经常性损益后的净利润4.86%4.91%0.230.25 详见《浙江杭州鑫富药业股份有限公司2005年半年度报告》（据“深圳证券交易所”；医药网整理，严禁转载）

本文来源于网络，版权归作者所有，如有侵权请联系网站客服。